Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

The DESTINY-Breast09 study, reported at ASCO, compared antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and ...

For the first time in a phase III trial, overall survival (OS) in unresectable pancreatic cancer improved significantly ...

Kirsten Bryant, a pancreatic cancer researcher at UNC Chapel Hill, points to cancerous cell samples that have been dosed at ...

The novel antibody-drug conjugate EBC-129 has been fast tracked by the FDA for approval in pancreatic ductal adenocarcinoma.

Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...

liver cancer chances almost quadrupled for men and increased five-fold for women. And pancreatic cancer risk almost doubled for women and increased by 74% for men. “The significance of [these ...

The company highlighted its focus on clinical trials, particularly the RASOLUT-302 trial for second-line pancreatic cancer ... median progression free survival, median overall survival that ...

Pancreatic cancer has a low survival ... inexpensive blood test that they say can detect pancreatic cancer — even in its early stages. Using a small blood sample, researchers from Oregon Health ...